Interestingly, this study showed that the highest number of responses occurred in ABC tumors that lacked BCR mutations (9/29; 31%) implying that BCR signaling in ABC DLBCL is not dependent on the presence of BCR mutations and may be activated via other mechanisms [14]. This evidence concerns the gene BCR and aneurysmal bone cyst.